Intravenous Immunoglobulin Market Size, Share, And Growth Report 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global intravenous immunoglobulin market, 2016-2025 (USD Billion)
  • 2.2. Global intravenous immunoglobulin market: Snapshot
•  
• Chapter 3. Intravenous Immunoglobulin Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Intravenous Immunoglobulin Market drivers: impact analysis
    • 3.2.2. The high rate of nutritional deficiency globally
    • 3.2.3. The increasing number of hemophilic patients
    • 3.2.4. Improved technology for high production of intravenous immunoglobulin and enhancement of purification techniques
    • 3.2.5. Government initiatives for improving healthcare facilities in developing countries
    • 3.2.6. Growing R&D in intravenous immunoglobulin medications
  • 3.3. Market Restraints
    • 3.3.1. Global Intravenous Immunoglobulin Market restraints: Impact analysis
    • 3.3.2. The high cost of treatment
    • 3.3.3. Lack of awareness
    • 3.3.4. Potential side-effects of intravenous immunoglobulin medicines
  • 3.4. Opportunities
    • 3.4.1. Evolving market
    • 3.4.2. Advanced technology
    • 3.4.3. Growing immunodeficiency
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by component
    • 3.6.2. Market attractiveness analysis, by application
    • 3.6.3. Market attractiveness analysis, by End-user
    • 3.6.4. Market attractiveness analysis, by region
•  
• Chapter 4. Global Intravenous Immunoglobulin Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global intravenous immunoglobulin market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New instruments launch
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
•  
• Chapter 5. Global Intravenous Immunoglobulin Market - Component Analysis
  • 5.1. Global intravenous immunoglobulin market: component overview
    • 5.1.1. Global intravenous immunoglobulin market share, by component, 2018 and 2025
  • 5.2. IgG
    • 5.2.1. Global intravenous immunoglobulin market for IgG, 2016-2025 (USD Billion)
  • 5.3. IgA
    • 5.3.1. Global intravenous immunoglobulin market for IgA, 2016-2025 (USD Billion)
  • 5.4. IgM
    • 5.4.1. Global intravenous immunoglobulin market for IgM, 2016-2025 (USD Billion)
  • 5.5. IgE
    • 5.5.1. Global intravenous immunoglobulin market for IgE, 2016-2025 (USD Billion)
  • 5.6. IgD
    • 5.6.1. Global intravenous immunoglobulin market for IgD, 2016-2025 (USD Billion)
•  
• Chapter 6. Global Intravenous Immunoglobulin Market - Application Analysis
  • 6.1. Global intravenous immunoglobulin market: application overview
    • 6.1.1. Global intravenous immunoglobulin market share, by application, 2018 and 2025
  • 6.2. Immunodeficiency Diseases
    • 6.2.1. Intravenous immunoglobulin market for immunodeficiency disease, 2016-2025 (USD Billion)
  • 6.3. Chronic Inflammatory Demyelinating Polyneuropathy
    • 6.3.1. Global intravenous immunoglobulin market for chronic inflammatory demyelinating polyneuropathy, 2016-2025 (USD Billion)
  • 6.4. Idiopathic Thrombocytopenic Purpura
    • 6.4.1. Global intravenous immunoglobulin market for idiopathic thrombocytopenic purpura, 2016-2025 (USD Billion)
  • 6.5. Multifocal Motor Neuropathy
    • 6.5.1. Global intravenous immunoglobulin market for multifocal motor neuropathy, 2016-2025 (USD Billion)
  • 6.6. Hypogammaglobulinemia
    • 6.6.1. Global intravenous immunoglobulin market for hypogammaglobulinemia, 2016-2025 (USD Billion)
  • 6.7. Myasthenia Gravis
    • 6.7.1. Global intravenous immunoglobulin market for myasthenia, 2016-2025 (USD Billion)
  • 6.8. Inflammatory Myopathies
    • 6.8.1. Global intravenous immunoglobulin market for inflammatory myopathies, 2016-2025 (USD Billion)
  • 6.9. Specific Antibody Deficiency
    • 6.9.1. Global intravenous immunoglobulin market for specific antibody deficiency, 2016-2025 (USD Billion)
  • 6.10. Guillain-Barre syndrome
    • 6.10.1. Global intravenous immunoglobulin market for Guillain-Barre syndrome, 2016-2025 (USD Billion)
  • 6.11. Others
  • 6.11.1. Global intravenous immunoglobulin market for others, 2016-2025 (USD Billion)
•  
• Chapter 7. Global Intravenous Immunoglobulin Market -End-user Analysis
  • 7.1. Global intravenous immunoglobulin market: End-user overview
    • 7.1.1. Global intravenous immunoglobulin market share, by End-user, 2018 and 2025
  • 7.2. Hospitals
    • 7.2.1. Global intravenous immunoglobulin market for hospitals, 2016-2025 (USD Billion)
  • 7.3. Clinics
    • 7.3.1. Global intravenous immunoglobulin market for clinics, 2016-2025 (USD Billion)
  • 7.4. Homecare Setting
    • 7.4.1. Global intravenous immunoglobulin market for homecare setting, 2016-2025 (USD Billion)
•  
• Chapter 8. Global Intravenous Immunoglobulin Market - Regional Analysis
  • 8.1. Global intravenous immunoglobulin market: regional overview
    • 8.1.1. Global intravenous immunoglobulin market share, by region, 2018 and 2025
  • 8.2. North America
    • 8.2.1. North America intravenous immunoglobulin market, 2016-2025 (USD Billion)
    • 8.2.2. North America intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
    • 8.2.3. North America intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
    • 8.2.4. North America intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
    • 8.2.5. The U.S.
      • 8.2.5.1. The U.S. intravenous immunoglobulin market, by component, 2016-2025 (USD Billion)
      • 8.2.5.2. The U.S. intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
      • 8.2.5.3. The U.S. intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
    • 8.2.6. Canada
      • 8.2.6.1. Canada intravenous immunoglobulin market, by component, 2016-2025 (USD Billion)
      • 8.2.6.2. Canada intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
      • 8.2.6.3. Canada intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe intravenous immunoglobulin market revenue, 2016-2025 (USD Billion)
    • 8.3.2. Europe intravenous immunoglobulin market revenue, by component, 2016-2025( USD Billion)
    • 8.3.3. Europe intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
    • 8.3.4. Europe intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
    • 8.3.5. U.K.
      • 8.3.5.1. U.K. intravenous immunoglobulin market, by component, 2016-2025 (USD Billion)
      • 8.3.5.2. U.K. intravenous immunoglobulin market, by application, 2016-2025 (USD Billion)
      • 8.3.5.3. U.K. intravenous immunoglobulin market, by End-user, 2016-2025 (USD Billion)
    • 8.3.6. Germany
      • 8.3.6.1. Germany intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
      • 8.3.6.2. Germany intravenous immunoglobulin market, by application, 2016-2025 (USD Billion)
      • 8.3.6.3. Germany intravenous immunoglobulin market, by End-user ,2016-2025 (USD Billion)
    • 8.3.7. France
      • 8.3.7.1. France intravenous immunoglobulin market revenue, by component, 2016-20259USD Billion)
      • 8.3.7.2. France intravenous immunoglobulin market, by application, 2016-2025 (USD Billion)
      • 8.3.7.3. France intravenous immunoglobulin market, by End-user,2016-2025 (USD Billion)
    • 8.3.8. Rest of Europe
      • 8.3.8.1. Rest of Europe intravenous immunoglobulin market revenue, by component, 2016-2025 USD Billion)
      • 8.3.8.2. Rest of Europe intravenous immunoglobulin market, by application, 2016-2025 (USD Billion)
      • 8.3.8.3. Rest of Europe intravenous immunoglobulin market, by End-user, 2016-2025 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific intravenous immunoglobulin market, 2016-2025 (USD Billion)
    • 8.4.2. Asia Pacific intravenous immunoglobulin market revenue, by component, 2016-20259 (USD Billion)
    • 8.4.3. Asia Pacific intravenous immunoglobulin market revenue, by application, 2016-20259 (USD Billion)
    • 8.4.4. Asia Pacific intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
    • 8.4.5. China
      • 8.4.5.1. China intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
      • 8.4.5.2. China intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
      • 8.4.5.3. China intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
    • 8.4.6. Japan
      • 8.4.6.1. Japan intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
      • 8.4.6.2. Japan intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
      • 8.4.6.3. Japan intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
    • 8.4.7. India
      • 8.4.7.1. India intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
      • 8.4.7.2. India intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
      • 8.4.7.3. India intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
    • 8.4.8. Rest of Asia Pacific
      • 8.4.8.1. Rest of Asia Pacific intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
      • 8.4.8.2. Rest of Asia Pacific intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
      • 8.4.8.3. Rest of Asia Pacific intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America intravenous immunoglobulin market, 2016-2025 (USD Billion)
    • 8.5.2. Latin America intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
    • 8.5.3. Latin America intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
    • 8.5.4. Latin America intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
      • 8.5.5.2. Brazil intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
      • 8.5.5.3. Brazil intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
    • 8.5.6. Rest of Latin America
      • 8.5.6.1. Rest of Latin America intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
      • 8.5.6.2. Rest of Latin America intravenous immunoglobulin market revenue, by application, 2016-2025 (USD Billion)
      • 8.5.6.3. Rest of Latin America intravenous immunoglobulin market revenue, by End-user, 2016-2025 (USD Billion)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa intravenous immunoglobulin market, 2016-2025 (USD Billion)
    • 8.6.2. The Middle East and Africa intravenous immunoglobulin market revenue, by component, 2016-2025 (USD Billion)
    • 8.6.3. The Middle East and Africa intravenous immunoglobulin market, by application, 2016-2025 (USD Billion)
    • 8.6.4. The Middle East and Africa intravenous immunoglobulin market, by End-user, 2016-2025 (USD Billion)
•  
• Chapter 9. Company Profile
  • 9.1. LFB Biotechnologies
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategy
    • 9.1.5. Recent Developments
  • 9.2. Biotest AG
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategy
    • 9.2.5. Recent Developments
  • 9.3. Octapharma AG
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategy
    • 9.3.5. Recent Developments
  • 9.4. Grifols S.A.
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategy
    • 9.4.5. Recent Developments
  • 9.5. CSL Behring
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategy
    • 9.5.5. Recent Developments
  • 9.6. China Biologics Products
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategy
    • 9.6.5. Recent Developments
  • 9.7. Kedrion Biopharma
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategy
    • 9.7.5. Recent Developments
  • 9.8. BDI Pharma
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategy
    • 9.8.5. Recent Developments
  • 9.9. Shire
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategy
    • 9.9.5. Recent Developments
  • 9.10. CSL Behring
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product Portfolio
    • 9.10.4. Business Strategy
    • 9.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market methodology
3. Global intravenous immunoglobulin market, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global intravenous immunoglobulin market attractiveness analysis, by component
6. Global intravenous immunoglobulin market attractiveness analysis, by application
7. Global intravenous immunoglobulin market attractiveness analysis, by End-user
8. Global intravenous immunoglobulin market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global intravenous immunoglobulin market share by component, 2018 and 2025
11. Global intravenous immunoglobulin market for IgG, 2016–2025 (USD Billion)
12. Global intravenous immunoglobulin market for IgA, 2016–2025 (USD Billion)
13. Global intravenous immunoglobulin market for IgM, 2016–2025 (USD Billion)
14. Global intravenous immunoglobulin market for IgE, 2016–2025 (USD Billion)
15. Global intravenous immunoglobulin market for IgD, 2016–2025 (USD Billion)
16. Global intravenous immunoglobulin market share by application, 2018 and 2025
17. Global intravenous immunoglobulin market for immunodeficiency diseases, 2016–2025 (USD Billion)
18. Global intravenous immunoglobulin market for chronic inflammatory demyelinating polyneuropathy, 2016–2025 (USD Billion)
19. Global intravenous immunoglobulin market revenue share for idiopathic thrombocytopenic purpura, 2018 and 2025
20. Global intravenous immunoglobulin market for multifocal motor neuropathy, 2016–2025 (USD Billion)
21. Global intravenous immunoglobulin market for hypogammaglobulinemia, 2016–2025 (USD Billion)
22. Global intravenous immunoglobulin market for myasthenia gravis, 2016–2025 (USD Billion)
23. Global intravenous immunoglobulin market for inflammatory myopathies, 2016–2025 (USD Billion)
24. Global intravenous immunoglobulin market for specific antibody deficiency, 2016–2025 (USD Billion)
25. Global intravenous immunoglobulin market for Guillain-Barre Syndrome, 2016–2025 (USD Billion)
26. Global intravenous immunoglobulin market for others, 2016–2025 (USD Billion)
27. Global intravenous immunoglobulin market share by End-user, 2018 and 2025
28. Global intravenous immunoglobulin market for hospitals, 2016–2025 (USD Billion)
29. Global intravenous immunoglobulin market for clinics, 2016–2025 (USD Billion)
30. Global intravenous immunoglobulin market for homecare settings, 2016–2025 (USD Billion)
31. Global intravenous immunoglobulin market share by region, 2018 and 2025
32. North America intravenous immunoglobulin market, 2016–2025 (USD Billion)
33. Europe intravenous immunoglobulin market, 2016–2025 (USD Billion)
34. Asia Pacific intravenous immunoglobulin market, 2016–2025 (USD Billion)
35. Latin America intravenous immunoglobulin market, 2016–2025 (USD Billion)
36. The Middle East and Africa intravenous immunoglobulin market, 2016–2025 (USD Billion)

Table Of Tables

List of Tables

1. Global intravenous immunoglobulin market: market snapshot
2. Drivers of the intravenous immunoglobulin market: impact analysis
3. Restraints of the intravenous immunoglobulin market: impact analysis
4. North America intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
5. North America intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
6. North America  intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
7. The U.S. intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
8. The U.S. intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
9. The U.S. intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
10. Canada intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
11. Canada intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
12. Canada intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
13. Europe intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
14. Europe intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
15. Europe intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
16. U.K. intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
17. U.K. intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
18. U.K. intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
19. Germany intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
20. Germany intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
21. Germany intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
22. France intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
23. France intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
24. France intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
25. Rest of Europe intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
26. Rest of Europe intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
27. Rest of Europe intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
28. Asia Pacific intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
29. Asia Pacific intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
30. Asia Pacific intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
31. China intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
32. China intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
33. China intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
34. Japan intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
35. Japan intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
36. Japan intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
37. India intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
38. India intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
39. India intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
40. Rest of Asia Pacific intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
41. Rest of Asia Pacific intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
42. Rest of Asia Pacific intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
43. Latin America intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
44. Latin America intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
45. Latin America intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
46. Brazil intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
47. Brazil intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
48. Brazil intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
49. Rest of Latin America intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
50. Rest of Latin America intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
51. Rest of Latin America intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)
52. The Middle East and Africa intravenous immunoglobulin market revenue, by component, 2016–2025 (USD Billion)
53. The Middle East and Africa intravenous immunoglobulin market revenue, by application, 2016–2025 (USD Billion)
54. The Middle East and Africa intravenous immunoglobulin market revenue, by End-user, 2016–2025 (USD Billion)